Covid-19 update: SA reports 5,284 new cases and 41 deaths

South Africa has reported 5,284 new cases of Covid-19 in the last 24 hours, according to the National Institute of Infectious Diseases.NICD), a division of the National Health Laboratory Service, said Wednesday.

This brings the total number of laboratory-confirmed cases to 3,941,045. This increase represents a positive outcome rate of 17.3%.

Today, the majority of new Covid-19 cases are in Gauteng (32%), followed by the Western Cape (28%). KwaZulu-Natal accounted for 13%; The Eastern Cape was 9%; The Free State accounted for 6%; the Northwest accounted for 4%; Mpumalanga and the Northern Cape accounted for 3% each; and Limpopo accounted for 2% of today’s cases.

The country has recorded 41 deaths, 6 of which occurred in the last 24-48 hours. This brings the total death toll to date to 101,043.

Over the past 24 hours, the number of hospitalizations has increased by 113.

25,138,638 tests were carried out in both the public and private sectors.

US pharmaceutical giant On Wednesday, Pfizer said it would sell its patented drugs on a non-commercial basis to the world’s poorest countries as part of a new initiative announced at the World Economic Forum in Davos.

“It’s time to start closing this gap” between people who have access to the latest treatments and those who don’t, chief executive Albert Burla said at a press conference at an exclusive gathering of Swiss mountain resorts.

ALSO READ: Covid in South Africa: what to expect in the short and long term

The Deal for a Healthier World focuses on five areas — infectious diseases, cancer, inflammation, rare diseases, and women’s health — where Pfizer currently owns 23 patents, including those for Comirnaty and Paxlovid, a Covid vaccine, and an oral treatment.

“This transformational commitment will increase access to Pfizer’s patented medicines and vaccines available in the United States and the European Union to nearly 1.2 billion people,” Angela Hwang, group president of Pfizer Biopharmaceuticals, told AFP.

Additional AFP reporting